STOCK TITAN

CareDx to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in the following investor conferences.

  • Jefferies London Healthcare Conference 2024 in London, UK. Presentation on Tuesday, November 19 at 9:00 AM GMT/4:00 AM EST
  • Stephens Investment Conference (NASH2024) in Nashville, TN. Fireside chat on Thursday, November 21 at 8:00 AM CST/9:00 AM EST
  • Piper Sandler Healthcare Conference in New York, NY. Presentation on Wednesday, December 4 at 10:10 AM EST

To listen to the webcast, please visit the Events & Presentations section of CareDx’s Investor Relations website at: investors.caredx.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

CareDx, Inc.

Media Relations

Anna Czene

818-731-2203

aczene@caredx.com



Investor Relations

Greg Chodaczek

investor@caredx.com

Source: CareDx, Inc.

Caredx

NASDAQ:CDNA

CDNA Rankings

CDNA Latest News

CDNA Stock Data

976.60M
53.24M
3.37%
94.9%
9.34%
Diagnostics & Research
Services-medical Laboratories
Link
United States
BRISBANE